Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Helicobacter|August 29, 2022
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradicationYi Hu, Xin Xu, Yao-Bin Ouyang, et al.
World Journal of Gastroenterology|April 29, 2024
Comparative transcriptomic analysis reveals the molecular changes of acute pancreatitis in experimental modelsPan Zheng, Xue-Yang Li, Xiao-Yu Yang, et al.
Helicobacter|April 25, 2022
Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot studyYi Hu, Xin Xu, Yao-Bin Ouyang, et al.
Frontiers in Cellular and Infection Microbiology|June 20, 2022
Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for <i>Helicobacter pylori</i> EradicationYi Hu, Xin Xu, Yao-Bin Ouyang, et al.
Cancer Letters|March 9, 2019
Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin β-1/NF-κB signaling pathwayYi Hu, Jian-Ping Liu, Xue-Yang Li, et al.
Frontiers in Immunology|February 2, 2023
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating <i>Helicobacter pylori</i> infection: A prospective, open-labeled, randomized non-inferiority clinical studyYi Hu, Xin Xu, Xiao-Shun Liu, et al.
Oncogene|February 12, 2025
Helicobacter pylori activates DOPEY1 to promote p53 degradation through the USP7/TRIP12 axis in gastric tumorigenesisYan-An Zhou, Nian-Shuang Li, Yu-Chen Zhu, et al.
Pageof 2